000 01366 a2200373 4500
005 20250517231633.0
264 0 _c20190524
008 201905s 0 0 eng d
022 _a1347-5223
024 7 _a10.1248/cpb.c18-00308
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArai, Midori A
245 0 0 _aSynthesis and Evaluation of Fuligocandin B Derivatives with Activity for Overcoming TRAIL Resistance.
_h[electronic resource]
260 _bChemical & pharmaceutical bulletin
_c2018
300 _a810-817 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDrug Design
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMolecular Docking Simulation
650 0 4 _aProline
_xanalogs & derivatives
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTNF-Related Apoptosis-Inducing Ligand
_xmetabolism
700 1 _aMasuda, Ayaka
700 1 _aSuganami, Akiko
700 1 _aTamura, Yutaka
700 1 _aIshibashi, Masami
773 0 _tChemical & pharmaceutical bulletin
_gvol. 66
_gno. 8
_gp. 810-817
856 4 0 _uhttps://doi.org/10.1248/cpb.c18-00308
_zAvailable from publisher's website
999 _c28691792
_d28691792